Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Generic drugs in the US are too cheap to be sustainable, experts say

Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of business

The Guardian - US

Union Cabinet approves memoranda on health products with Netherlands, Dominican Republic, Ecuador

“The Union Cabinet on January 18 approved separate memorandum with the Netherlands, Dominican Republic and Ecuador on cooperation in the field of medical products regulation,” an official statement said.

The Hindu

3 A-Rated Medical Stocks to Watch and Buy

The medical industry is set for significant growth due to technological advances, increased demand for medicines due to an aging population, escalating healthcare costs, and the rising need for quality healthcare. Therefore, it could be wise to buy fundamentally strong medical stocks GSK (GSK), National HealthCare (NHC), and MiMedx Group…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle

Natera stock surged Wednesday after a jury said the company must pay Ravgen $57 million in a patent lawsuit — far below expectations.

Investors Business Daily

What to know about January's annual drug price hikes

Spoiler: There are some decreases this year, too. Here's an overview of the changing prices and what to make of them.

WEKU

Exclusive: AAP govt procured drugs from 2 blacklisted pharma firms with many failed quality tests

Six drugs from six pharma firms have fuelled a tussle between the Centre and the Delhi government, with both sides trying to blame each other for substandard medicines making their way to the capital’s government hospitals.

Newslaundry

UK sets up critical imports council to protect vital supplies

Group will tackle potential restrictions to items such as medicine amid geopolitical and climate threats

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

NHS Medicine Shortage Raises Concerns Over Patient Safety

There is a notable 100 per cent surge in medicine shortages compared to January 2022 as seen in the deteriorating health of patients across the UK.

International Business Times UK

Crispr Wins Its Second Gene-Editing Approval In Another Boost To Vertex Stock

Crispr won its second gene-editing approval on Tuesday — two months ahead of time. But CRSP stock slipped, and VRTX stock rose minimally.

Investors Business Daily

3 Pharma Stocks for January 2024 Profits

The pharmaceutical industry is thriving, fueled by steady demand for drugs, cost-efficient alternative discoveries, and rapid technological innovations. Hence, fundamentally strong pharma stocks Novo Nordisk (NVO), Eton Pharmaceuticals (ETON), and Pacira BioSciences (PCRX) might be profitable buys now. Read on….

StockNews.com

Why is there a medicine shortage in the UK? Pharmacists urge political parties to prioritise issue

34 and 11 serious shortage protocols (SSPs) were issued in 2022 and 2023 respectively

Evening Standard

Synthetic opioids could fuel ‘second wave’ of UK drug deaths crisis, experts warn

Government urged to act as experts sound the alarm on nitazenes, with 54 deaths in past six months likely ‘tip of the iceberg’

The Independent UK

Here's Why Regeneron Pharmaceuticals Just Hit A Record High — Again

There's more than Eylea to like about Regeneron Pharmaceuticals right now, an analyst said Friday as REGN stock touched another record high.

Investors Business Daily

Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space

There's a revolution in immunology that could completely shift a paradigm biotech stocks. And Big Pharma is paying billions to get in.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

State Economics — Spotlight on New England: The Kiplinger Letter

After a better-than-expected 2023, New England states will see only modest employment growth in 2024.

StockNews.com

Are These 4 Biotech Stocks Worth Buying in 2024?

The need for innovative healthcare solutions, personalized medicines and treatments, and the use of advanced technologies will propel the biotech industry forward. Amid this backdrop, let’s explore the investment potential of biotech stocks TG Therapeutics (TGTX), Galapagos (GLPG), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR).

Top News

FDA allowing drug imports from Canada to lower prescription costs

Get the latest on the FDA's decision to allow Florida to import medications from Canada, potentially reducing prescription costs for Americans. Learn about...

Investors Business Daily

Novo Nordisk, IBD Stock Of The Day, Flashes Buy Signal Amid The Weight-Loss Craze

Novo Nordisk stock is Friday's IBD Stock Of The Day. Shares are in a buy zone after the firm inked deals in the weight-loss drugs space.

The Independent UK

US biotech company halts sales of DNA kits in Tibet, as lawmakers mull more export controls on China

Thermo Fisher, an American biotech company, has halted sales of its DNA testing products in Tibet, amid concerns that its products might have assisted the Chinese government in a surveillance campaign in the ethnic region

Investors Business Daily

Stock Market Skids To Start 2024 As Tesla, Apple Stumble, Mobileye Crashes: Weekly Review

The S&P 500 snapped a nine-week win streak, but tried to find support. Tesla, Apple and Mobileye were key losers.

1 … 16 17 18 19

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.